Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You should check the official Nasdaq website.it was already listed there for more than week.
Old news
Did you take into account that the last patient was enrolled in September 2016 and not the end of December 2016? Because that could gave MK 3 months in advance
#Keep in mind: you cannot fake or fraud tumor shrinkage/elimination#
Once again:you cannot fake or fraud tumor shrinkage. That is the best evidence MK works.
When the big guys are loaded it’s free to skyrocket.
We are talking about stage 3 and 4a H&N Cancer, don’t forget that.
Well, one of the easiest things for a doctor is to determine if someone is dead or alive. Once a patient has died, it is immediately reported and updated to the CRO, within 2 working days. Wonen that patient is the 298th patient that is death, the CRO will immediately inform the company. So to summarize: the 298th will be 8k_filed within 3-4working days.
Indeed, they need to 8k-file this. So, again a VERY good sign the 298th event has not occured yet.
Remember this: you cannot fake/fraud with tumor shrinkage. So we are already certain that this part of Multikine works. For the overall survival we can rely on the phase 1 and phase 2 data and two positive interim data&safety board recommendations, the VERY logica working mechanism and the duration of the trial.
Thank you. We can all agree that $1-2.9b is too low and $20-32b is too high. Should be somewhere in between for a buyout. I would be happy with $10b (including the production facility, LEAPS and all patents, including potential of Multikine for a lot of other cancer and I mean A LOT OF OTHER CANCERS)
$14/share is too low for an orphan drug which will be used as first-in-line treatment for H&N cancer prior to surgery. Should be worth at least $2b or $40/share
Well, the maximum warrant conversion price is $2.74. So warrant holders do anything to make as much money possible and that is by converting their warrants at $2.74. The good thing is that the share price is difficult to keep below $2.74 as you start seeing at the first opening hours.
The clock is now ticking in our favour.
These are all very valuable explanations for pages 5-6-7 of the 2016 annual report. AF posted an understandable concern, but I think the answer to the concern is not the science but the former CRO.
The best proof Multikine has a decent chance of succeess is the fact the tumor size could be elminated or reduced in 50% of the patients.
Good news also is the 298th hasn't occured.
I remain my market cap target of at least $2b if phase 3 results are positive.
If you see MBOT raised from $1/share to $20/share on positive preclinical results, CVM could do that too.
Good sign share price is trading above conversion price. Maybe the results will soon be released.
If postive a MC of $2b ($40/share) would be very reasonable.
Anyway,Thank you all for answering my questions. Your answers sound logical.
Who am I? Are you on drugs?
I hate to say it,but AF is right 90% of the time.
Ok. Thank you.
In these pages they are also talking about the possibility of doing a second phase 3 trial. That's also concerning. Thanks for your opinion in advance
What's your opinion on pages5,6,7? https://www.sec.gov/Archives/edgar/data/725363/000165495416004867/cvm_10k.htm
Thank you
Can I see your spreadsheet?
Just mark the previous post. If P3 is succesfull a buyout will follow for at least $4b.
Let me help you as a professional in the medical field:
1. Multikine is indicated as first in line treatment of H&N cancer and NOT for recurrent H&N cancer
2. Multikine is indicated for use PRIOR to surgery and possible chemo ...
Therefore Multikine is unique and as groundbreaking as CAR-T cells. If successful in P3, we may expect a buyout for not less than $4 billion
CVM will be presenting at the bio investors conference in February.
https://www.bio.org/sites/default/files/CEO%202019%20Presenting%20Companies.xlsx
Floor price(if you read the entire statement):$0.45/share
So another R/S will follow afterwarts
Australia’s Pro-Crypto Stance Continues as Politicians Invest in Bitcoin
https://www.newsbtc.com/2018/03/26/australian-politicians-invest-in-bitcoin-possibly-due-to-pro-crypto-legislature
Operator of Toronto Stock Exchange Announces Launch of Cryptocurrency Brokerage Platform
https://www.newsbtc.com/2018/03/25/operator-toronto-stock-exchange-announces-launch-cryptocurrency-brokerage-platform
I took another look at the team. These guys are the best of the best.
Market rally is over. Investors will invest in Bitcoin now. Better than gold, a lot better.
No, I rarely post any messages, but enjoy reading them.
You are welcome. Their partnership with singularity.net is astonishing and also the fact that they made $8M profit the last six months. Bitcoin is becoming an established product and government will change their mindset from hostile to supportive. $50000 for 1 bitcoin is really attainable for this year. Could be higher as well.
I agree. You are welcome.
Bitcoin headed to $100,000 in 2018, says analyst who predicted last year's price rise.
https://www.google.be/amp/s/www.cnbc.com/amp/2018/01/16/bitcoin-headed-to-100000-in-2018-analyst-who-forecast-2017-price-move.html
Great stock. I am in on the Australian Exchange
No, its' technology is unique, groundbreaking and patented.
I'm anticipating a December crash for MBOT
MBOT: great short here.No significant milestones for the next 12 months, no revenues through commercialization, lots of cash burn, December tax coming and almost under the dollar.
GURE:going to explode Monday!"Shareholders’ Equity increased 8.9%* to $8.13* per diluted share since December 31, 2016."
https://globenewswire.com/news-release/2017/08/11/1083874/0/en/Gulf-Resources-Reports-Second-Quarter-2017-Financial-Results.html
GURE:going to explode on Monday! "Shareholders’ Equity increased 8.9%* to $8.13* per diluted share since December 31, 2016."
https://globenewswire.com/news-release/2017/08/11/1083874/0/en/Gulf-Resources-Reports-Second-Quarter-2017-Financial-Results.html
"Shareholders’ Equity increased 8.9%* to $8.13* per diluted share since December 31, 2016." Going to explode on Monday!!!!
https://globenewswire.com/news-release/2017/08/11/1083874/0/en/Gulf-Resources-Reports-Second-Quarter-2017-Financial-Results.html